PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schärli, S.* ; Luther, F.* ; Di Domizio, J.* ; Hillig, C. ; Radonjic-Hoesli, S.* ; Thormann, K.* ; Simon, D.* ; Møller Rønnstad, A.T.* ; Ruge, I.F.* ; Fritz, B.G.* ; Bjarnsholt, T.* ; Vallone, A.* ; Kezic, S.* ; Menden, M.P. ; Roesner, L.M.* ; Werfel, T.* ; Thyssen, J.P.* ; Eyerich, S. ; Gilliet, M.* ; Bertschi, N.L.* ; Schlapbach, C.*

IL-9 sensitizes human Th2 cells to pro-inflammatory IL-18 signals in atopic dermatitis.

J. Allergy Clin. Immunol. 155:23 (2024)
Publ. Version/Full Text Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: T helper 2 (Th2) cells crucially contribute to the pathogenesis of atopic dermatitis (AD) by secreting high levels of IL-13 and IL-22. Yet, the upstream regulators that activate Th2 cells in AD skin remain unclear. IL-18 is a putative upstream regulator of Th2 cells as it is implicated in AD pathogenesis and has the capacity to activate T cells. OBJECTIVE: To decipher the role of IL-18 in Th2 responses in blood and skin of AD patients. METHODS: PBMCs and skin biopsies from AD patients and healthy donors were used. Functional assays were performed ex vivo using stimulation or blocking experiments. Analysis was performed using flow cytometry, bead-based multiplex assays, RT-qPCR, RNA-seq, western blotting, and spatial sequencing. RESULTS: IL-18Rα+ Th2 cells were enriched in blood and lesional skin of AD patients. Of all the cytokines for which Th2 cells express the receptor, only IL-9 was able to induce IL-18R via an IL-9R-JAK1/JAK3-STAT1 signaling pathway. Functionally, stimulation of circulating Th2 cells with IL-18 induced secretion of IL-13 and IL-22, an effect that was enhanced by co-stimulation with IL-9. Mechanistically, IL-18 induced Th2 cytokines via activation of IRAK4, NF-κB, and AP-1 signaling in Th2 cells, and neutralization of IL-18 inhibited these cytokines in cultured explants of AD skin lesions. Finally, IL-18 protein levels correlated positively with disease severity in lesional AD skin. CONCLUSION: Our data identify a novel IL-9-IL-18 axis that contributes to Th2 responses in AD. Our findings suggest that both IL-9 and IL-18 could represent upstream targets for future treatment of AD.
Impact Factor
Scopus SNIP
Altmetric
11.400
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Il-9 Receptor (il-9r) ; Atopic Dermatitis (ad) ; Interleukin-1 Receptor-associated Kinase 4 (irak4) ; Interleukin-18 (il-18) ; Interleukin-18 Receptor (il-18r) ; Interleukin-9 (il-9) ; Pathogenic Th2 Cells (pth2) ; Upstream Regulator Of Th2 Cells; T-cells; Interleukin-18; Activation; Biomarkers; Filaggrin; Loci; Ige
Language english
Publication Year 2024
HGF-reported in Year 2024
ISSN (print) / ISBN 0091-6749
e-ISSN 1097-6825
Journal The journal of allergy and clinical immunology
Quellenangaben Volume: 155, Issue: 2, Pages: , Article Number: 23 Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)
Institute for Allergy Research (IAF)
POF-Topic(s) 30205 - Bioengineering and Digital Health
30202 - Environmental Health
Research field(s) Enabling and Novel Technologies
Allergy
PSP Element(s) G-554700-001
G-505490-001
Grants Swiss National Science Foundation (SNF)
Bio21 Molecular Science and Biotechnology Institute
Deutsche Forschungsgemeinschaft through TUM International Graduate School of Science and Engineering (IGSSE)
SKINTEGRITY.CH collaborative research project
Ruth & Arthur Scherbarth Foundation
Bern Center for Precision Medicine
Swiss National Science Foundation
DOI 10.1016/j.jaci.2024.10.027
WOS ID 001428763000001
Scopus ID 85211488977
PubMed ID 39521283
Erfassungsdatum 2024-11-20
[➜Report correction]